The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
The battle against COVID-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it.
A German factory is already busily churning out the little plastic tubes and is confident global needs can be met.
Otto-Philipp Braun, Co-director of Almo, Germany’s leading syringe manufacturer said on Sunday “There won’t be a shortage of syringes, even if we are facing a big challenge.”
The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs.
Every year, Almo churns out more than two billion syringes of various kinds.
The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia.
The first orders have already rolled in from Germany’s BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials.
Related posts:
Trump urges Georgia governor to halt run-off senate races
FG moves to boost local manufacturing of needles and syringes
Sabotage responsible for German Rail disruption – German Police
COVID-19 PPE fraud: 2 Nigerians arrested for defrauding German company of €14.7m
Abia Chinese shoe factory to generate 30,000 jobs
Gunman opens fire in Moscow factory, killing one
U.S.: Firefighters battle to put out inferno in a Melbourne industrial waste factory
BioNTech inaugurates first mRNA vaccine factory in Rwanda
